Related Experiment Video
Updated: Sep 1, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
Transcutaneous Electrical Acustimulation Improves Irritable Bowel Syndrome With Constipation by Accelerating Colon
Zhihui Huang1, Zhenghua Lin2, Chenhong Lin1
1Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Transcutaneous electrical acustimulation (TEA) effectively treats constipation and abdominal pain in irritable bowel syndrome with constipation (IBS-C). This therapy accelerates colon transit and enhances quality of life by modulating autonomic functions.
Area of Science:
- Gastroenterology
- Physiology
- Medical Devices
Background:
- Irritable bowel syndrome with constipation (IBS-C) is characterized by slow colon transit and visceral hypersensitivity.
- Current therapies often fail to address both abdominal pain and colonic motility issues effectively.
Purpose of the Study:
- To investigate the long-term efficacy and underlying mechanisms of transcutaneous electrical acustimulation (TEA) for managing IBS-C.
Main Methods:
- A randomized controlled trial involving 52 IBS-C patients comparing daily TEA versus sham-TEA for 4 weeks.
- Outcomes included complete spontaneous bowel movements (CSBMs), symptom severity, quality of life, colonic transit time, and anorectal physiology.
Main Results:
- TEA significantly improved CSBMs/week, reduced abdominal pain (VAS score), and improved quality of life compared to sham-TEA.
- TEA accelerated colonic transit time and increased rectal sensation thresholds.
- Increased vagal activity was observed with TEA, correlating with improved colon transit and CSBMs.
Conclusions:
- Transcutaneous electrical acustimulation (TEA) offers a promising therapeutic option for IBS-C.
- TEA alleviates constipation and abdominal pain by enhancing colon transit and modulating rectal sensation, potentially through autonomic pathways.
More Related Videos
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

